Form D · Other Technology

MENDEL BIOTECHNOLOGY INC

Hayward, CA · CIK 0001168936

Offering snapshot reported Nov 9, 2011 · SEC filing

Reported sold
$11.8M
Offering amount: $36M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 1, 2011
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 9, 2011Initial$11,846,950No comparison10SEC filing
Sep 23, 2011Initial$8,387,128No comparison10SEC filing
Oct 26, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jun 13, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Other
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-168430
SERIES F PREFERRED STOCK AND THE COMMON STOCK ISSUABLE UPON CONVERSION THEREOF.

Source: Form D, filed Nov 9, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Justin Adams Director
Richard Crowder Director
Peter Davis Director
Neal Gutterson Director, Executive
Gregory J. Ikonen Executive
Greg Ikonen Executive
Mark Lampert Director
Stephen Padgette Director
Steve Padgette Director
Brian Staskawicz Director
Neil Wallack Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
3935 Point Eden Way
Hayward, CA, 94545